Skip to content

Is Trending Inventory Albemarle Company (ALB) a Purchase Now?


Albemarle (ALB) is without doubt one of the shares most watched by guests recently. So, it could be a good suggestion to assessment among the components that may have an effect on the near-term efficiency of the inventory.

Shares of this specialty chemical substances firm have returned +14.8% over the previous month versus the Zacks S&P 500 composite’s +4.6% change. The Zacks Chemical – Diversified trade, to which Albemarle belongs, has gained 2.5% over this era. Now the important thing query is: The place might the inventory be headed within the close to time period?

Whereas media releases or rumors a few substantial change in an organization’s enterprise prospects normally make its inventory ‘trending’ and result in an instantaneous value change, there are all the time some basic info that ultimately dominate the buy-and-hold decision-making.

Revisions to Earnings Estimates

Reasonably than specializing in the rest, we at Zacks prioritize evaluating the change in an organization’s earnings projection. It is because we imagine the honest worth for its inventory is set by the current worth of its future stream of earnings.

Our evaluation is actually primarily based on how sell-side analysts masking the inventory are revising their earnings estimates to take the most recent enterprise tendencies under consideration. When earnings estimates for an organization go up, the honest worth for its inventory goes up as nicely. And when a inventory’s honest worth is greater than its present market value, buyers have a tendency to purchase the inventory, leading to its value transferring upward. Due to this, empirical research point out a robust correlation between tendencies in earnings estimate revisions and short-term inventory value actions.

For the present quarter, Albemarle is anticipated to publish earnings of $7.62 per share, indicating a change of +654.5% from the year-ago quarter. The Zacks Consensus Estimate has modified +17.5% during the last 30 days.

For the present fiscal 12 months, the consensus earnings estimate of $20.95 factors to a change of +418.6% from the prior 12 months. Over the past 30 days, this estimate has modified -4%.

For the subsequent fiscal 12 months, the consensus earnings estimate of $27.09 signifies a change of +29.3% from what Albemarle is anticipated to report a 12 months in the past. Over the previous month, the estimate has modified -4%.

With a formidable externally audited monitor report, our proprietary inventory ranking instrument — the Zacks Rank — is a extra conclusive indicator of a inventory’s near-term value efficiency, because it successfully harnesses the facility of earnings estimate revisions. The dimensions of the latest change within the consensus estimate, together with three different components associated to earnings estimates, has resulted in a Zacks Rank #3 (Maintain) for Albemarle.

The chart beneath reveals the evolution of the corporate’s ahead 12-month consensus EPS estimate:

12 Month EPS

Projected Income Progress

Though an organization’s earnings development is arguably the perfect indicator of its monetary well being, nothing a lot occurs if it can’t increase its revenues. It is virtually not possible for an organization to develop its earnings with out rising its income for lengthy intervals. Due to this fact, realizing an organization’s potential income development is essential.

For Albemarle, the consensus gross sales estimate for the present quarter of $2.6 billion signifies a year-over-year change of +191%. For the present and subsequent fiscal years, $7.43 billion and $9.76 billion estimates point out +123.3% and +31.4% modifications, respectively.

Final Reported Outcomes and Shock Historical past

Albemarle reported revenues of $2.09 billion within the final reported quarter, representing a year-over-year change of +151.9%. EPS of $7.50 for a similar interval compares with $1.05 a 12 months in the past.

In comparison with the Zacks Consensus Estimate of $2.12 billion, the reported revenues symbolize a shock of -1.23%. The EPS shock was +9.65%.

The corporate beat consensus EPS estimates in every of the trailing 4 quarters. The corporate topped consensus income estimates 3 times over this era.


No funding determination will be environment friendly with out contemplating a inventory’s valuation. Whether or not a inventory’s present value rightly displays the intrinsic worth of the underlying enterprise and the corporate’s development prospects is a necessary determinant of its future value efficiency.

Evaluating the present worth of an organization’s valuation multiples, reminiscent of its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash circulation (P/CF), to its Personal historic values ​​helps verify whether or not its inventory is pretty valued, overvalued, or undervalued, whereas evaluating the corporate relative to its friends on these parameters offers an excellent sense of how affordable its inventory value is.

The Zacks Worth Type Rating (a part of the Zacks Type Scores system), which pays shut consideration to each conventional and unconventional valuation metrics to grade shares from A to F (an An is best than a B; a B is best than a C; and so forth), is fairly useful in figuring out whether or not a inventory is overvalued, rightly valued, or quickly undervalued.

Albemarle is graded C on this entrance, indicating that it’s buying and selling at par with its friends. Click on right here to see the values ​​of among the valuation metrics which have pushed this grade.


The info mentioned right here and far different info on may assist decide whether or not or not it is worthwhile listening to the market buzz about Albemarle. Nonetheless, its Zacks Rank #3 does counsel that it could carry out in keeping with the broader market within the close to time period.

Zacks Names “Single Greatest Decide to Double”

From hundreds of shares, 5 Zacks specialists every have chosen their favourite to skyrocket +100% or extra in months to return. From these 5, Director of Analysis Sheraz Mian hand-picks one to have essentially the most explosive upside of all.

It is a little-known chemical firm that is up 65% over final 12 months, but nonetheless grime low cost. With unrelenting demand, hovering 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail buyers might bounce in at any time.

This firm might rival or surpass different latest Zacks’ Shares Set to Double like Boston Beer Firm which shot up +143.0% in little greater than 9 months and NVIDIA which boomed +175.9% in a single 12 months.

Free: See Our High Inventory and 4 Runners Up >>

Need the most recent suggestions from Zacks Funding Analysis? As we speak, you may obtain 7 Greatest Shares for the Subsequent 30 Days. Click on to get this free report

Albemarle Company (ALB) : Free Inventory Evaluation Report

To learn this text on click on right here.

Zacks Funding Analysis

The views and opinions expressed herein are the views and opinions of the creator and don’t essentially mirror these of Nasdaq, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *